Skip to Main Content

Paper Details

COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy.
ESMO Open
3
2022
Author NameAffiliation
Marc ZapatkaNational Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, German Cancer Research Center (DKFZ)
Michael Allg??uerUniversity Hospital Heidelberg
Albrecht StenzingerUniversity Hospital Heidelberg
Peter LichterNational Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, German Cancer Research Center (DKFZ)
Peter LichterNational Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, German Cancer Research Center (DKFZ)
  • 1 - 5

Datasets